Koncernomsætningen udgjorde 254,3 mio. kr., hvilket er 1,8 mio. kr. højere end samme periode sidste år. Udviklingen i omsætningen, omkostningerne og af- og nedskrivningerne kan primært henføres til lavere aktivitet i Lalandia, da påsken i 2025 ligger i april mod marts i 2024. Desuden har Parken har i perioden 1. januar til 31. marts 2025 dannet rammen om seks fodboldkampe, herunder en udsolgt UEFA Conference League-kamp mod Chelsea FC og en udsolgt landskamp mod Portugal. Primært resultat før amortiseringer ...

TORONTO, May 22, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoids, is pleased to announce the removal of all conditions precedent, related to its previously-announced agreement (the “Purchase Agreement”) for the sale of MediPharm’s facility in Hope, BC, (“Hope Facility”) to Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) for $4.5 million in cash (the “Transaction”). With these conditions now met, ...

BELGRADE, Mont., May 22, 2025 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. (“Bridger”, “the Company” or “Bridger Aerospace”), (NASDAQ: BAER, BAERW), one of the nation’s largest aerial firefighting companies, today announced that is has received two separate 120 day task orders from the US Forest Service, each for two of its CL-415EAF “Super Scooper” aircraft. These procurements are noteworthy in that they were received early in the wildfire year and are for a record 120 days each. “These task ...

Bundled Offer Includes Wegovy® at $199 and LifeMD’s Virtual Weight Loss Program for a Total First-Month Cost of $299, $599 per Month ThereafterNEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced a limited-time $299 introductory bundle for new self-pay patients prescribed Wegovy® (semaglutide), which includes both the medication and access to LifeMD’s virtual weight management program. As part of its collaboration with N ...

TAMPA, FL, May 22, 2025 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the “Company”), a holding company for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, today announced that Suren Ajjarapu, who has served as Chief Executive Officer (CEO) and Chairman of the Board of Directors (BOD), has stepped do ...

Daix, May 22, 2025 Pursuant to Article 241-2 of the AMF General Regulations (Règlement Général de l’Autorité des marchés financiers), the purpose of this description is to present the objectives and terms of the Company’s share repurchase program approved by the Ordinary General Meeting of May 22, 2025, it being specified that the Company does not to date intend to pursue any objective other than to animate the market under a liquidity agreement which has been in place since the listing on Euronext. Secur ...

Revolver Brewing launches a crisp, satisfying 4.0% ABV Texas-style lager just in time for the summer heat Revolver Brewing Y'all's Beer Revolver Brewing Y'all's Beer on a table Revolver Brewing Y'all's Beer Packaging Revolver Brewing Y'all's Beer Packaging GRANBURY, Texas, May 22, 2025 (GLOBE NEWSWIRE) -- Revolver Brewing, a craft beer pioneer in North Texas and craft beer brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), known for crafting bold and uniquely Texan beers, is proud to unveil i ...

VANCOUVER, British Columbia, May 22, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic neuroplastogen in the treatment of psychiatric and neurological disorders, is issuing the following press release in response to British Columbia Securities Commission’s (“BCSC”) May 21, 2025 news release. BetterLife announced on July 16, 2024, that it had amended ...

MELBOURNE, Australia and INDIANAPOLIS, May 22, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”) today announces it will host an Investor Day on Wednesday, June 11, 2025, in person, in New York City, from 8:30am ET to 12.00pm ET. Institutional investors, analysts and company guests are cordially invited to attend the session, which will focus on the growth opportunities across Telix’s commercial and clinical portfolio of precision medicine and therapeutic ...

Potential Additional Funding of up to $11MRaised subscription price by $1/month (ARPU increased from $3 to $5 since Jan. 1, 2025) *Financial Moves* Paid off $7M East West Bank loanExtinguished $4M short-term payablesExtended $5M of short-term payable to long-term debt *Planned Initiatives* Grow/close up to 75 B2B partnershipsConvert Additional Tesla subscribersPursue M&A opportunitiesExpand AI and data mining to monetize 60M databaseGrow current 1.5M subscribers and ad-supported users LOS ANGELES, May 22, 2 ...